Aggressive pharmacological treatment for reversing malignant bowel obstruction
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 28 (4), 412-416
- https://doi.org/10.1016/j.jpainsymman.2004.01.007
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancerSupportive Care in Cancer, 2001
- Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancerPublished by Wiley ,2000
- Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstructionSupportive Care in Cancer, 2000
- Role of Octreotide, Scopolamine Butylbromide, and Hydration in Symptom Control of Patients with Inoperable Bowel Obstruction and Nasogastric TubesJournal of Pain and Symptom Management, 2000
- The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction?Palliative Medicine, 2000
- Systematic review and meta-analysis of corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancersAnnals of Oncology, 1999
- Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstructionPalliative Medicine, 1998
- Octreotide may prevent definitive intestinal obstructionJournal of Pain and Symptom Management, 1997
- Octreotide prevents the pathological alterations of bowel obstruction in cancer patientsSupportive Care in Cancer, 1996
- Symptom control in terminally ill patients with malignant bowel obstruction (MBO)Journal of Pain and Symptom Management, 1994